Lifecore Biomedical, Inc. Financial Ratios — LFCR Stock

Profitability (USD)

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2025 Y
As of date	05/31/2012	05/31/2013	05/31/2014	05/31/2015	05/31/2016	05/31/2017	05/31/2018	05/31/2019	05/31/2020	05/31/2021	05/31/2022	05/31/2023	05/31/2024	05/31/2025	12/31/2025

Return on Common Equity (%)	8.88	13.75	10.03	6.43	-5.43	4.84	10.36	0.16	-15.24	-14.89	-80.32	- -	- -	-664.53	- -
Return on Assets (%)	5.25	7.94	6.33	4.1	-3.38	3.02	6.51	0.09	-7.2	-6.19	-30.02	-37.7	4.73	-15.7	- -
Return on Capital (%)	7.01	10.93	8.63	5.79	- -	4.25	- -	0.92	- -	- -	- -	- -	24.01	- -	- -
Return on Invested Capital (%)	5.13	8.1	5.64	4.7	- -	4.44	- -	1.17	- -	- -	- -	- -	-5.7	- -	- -
Gross Margin (%)	16.42	14.21	13.12	12.13	14	16.86	14.94	14.53	24.61	38.6	35.11	27.1	32.63	31.27	- -
EBITDA Margin (%)	6.36	7.28	5.73	4.74	4.77	5.94	4.96	4.07	6.23	24.19	13.15	-6.34	0.6	-3.09	- -
Operating Margin (%)	4.59	5.63	4.23	3.42	2.8	3.67	2.59	1.34	-5.54	4.49	-3.08	-19.1	-5.6	-9.32	- -
Incremental Operating Margin (%)	16.03	8.29	-13.33	-2.77	8.16	-54.27	-6.72	-18.34	- -	-22.64	- -	- -	- -	- -	-9.32
Pretax Margin (%)	6.39	7.3	6.28	3.98	-4.13	3.02	3.13	0.65	-19.15	-29.53	-18.59	-61.9	7.42	-30.01	- -
Profit Margin (%)	4	5.11	4.02	2.51	-2.44	2.25	4.74	0.07	-23.86	-32.01	-104.89	-96.41	9.37	-30.04	- -
Net Income to Common Margin (%)	4	5.11	4.02	2.51	-2.44	2.25	4.74	0.07	-23.86	-32.01	-104.89	-96.41	9.37	-32.62	- -
Effective Tax Rate (%)	35.42	29.3	35.37	36.08	- -	28.5	- -	41.7	- -	- -	- -	- -	1.92	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	7.89	- -
Sustainable Growth Rate (%)	8.88	13.75	10.03	6.43	-5.43	4.84	10.36	0.16	-15.24	-14.89	-80.32	- -	- -	-612.08	- -

Credit (USD)

Credit Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2025 Y
As of date	05/31/2012	05/31/2013	05/31/2014	05/31/2015	05/31/2016	05/31/2017	05/31/2018	05/31/2019	05/31/2020	05/31/2021	05/31/2022	05/31/2023	05/31/2024	05/31/2025	12/31/2025

Total Debt	59	44	34	43	61	54	73	153	221	216	150	113	129	131	143
ST Debt	19	10	6	8	11	8	32	62	93	31	143	2	5	4	1
LT Debt	40	34	28	34	50	46	41	91	128	185	8	111	124	127	141
Total Debt/EBITDA	2.92	1.38	1.26	1.66	2.69	1.93	2.81	6.72	22.18	8.85	10.27	-17.21	167.93	-32.88	- -
Net Debt/EBITDA	1.82	0.95	0.74	1.11	2.08	1.58	2.55	6.51	19.05	7.9	16.05	-12.62	151.7	-30.7	- -
Total Debt/EBIT	4.05	1.78	1.7	2.3	4.57	3.13	5.37	20.41	-24.93	47.63	-43.77	-5.71	-17.9	-10.9	- -
Net Debt/EBIT	2.52	1.23	1	1.54	3.55	2.56	4.89	19.79	-21.42	42.53	-68.41	-4.19	-16.17	-10.18	- -
EBITDA to Interest Expense	21.74	16.02	16.55	13.97	11.46	15.29	13.33	4.34	2.15	2.73	0.95	-0.37	0.04	-0.18	- -
EBITDA-CapEx/Interest Expense	15.96	11.6	7.53	4.4	-8.52	2.7	-3.89	-4.21	-3.6	-0.09	-0.99	-1.59	-0.97	-0.78	- -
EBIT to Interest Expense	15.69	12.38	12.24	10.09	6.73	9.45	6.97	1.43	-1.91	0.51	-0.22	-1.12	-0.4	-0.54	- -
Interest Expense	1	2	2	2	2	2	2	5	5	9	15	18	18	22	- -
Common Equity/Total Assets	53.92	61.42	64.75	63.05	61.5	63.19	62.41	52.04	42.68	40.32	31.97	-1.67	4.46	0.56	-6.12
Long-Term Debt/Equity (%)	26.59	19.05	13.83	15.52	23.44	20.18	16.23	33.58	55.29	91.36	8.72	- -	1,093.46	9,505.91	- -
Long-Term Debt/Capital (%)	19.14	15.3	11.84	13.01	18.2	16.32	12.6	21.46	28.25	44.25	3.22	102.2	88.41	96.1	110.03
Long-Term Debt/Total Assets (%)	14.51	11.81	9.03	9.86	14.53	12.84	10.13	17.48	23.6	36.84	2.79	43.69	48.72	53.06	60.85
Total Debt/Equity (%)	38.92	24.56	16.79	19.32	28.8	23.66	28.88	56.49	95.7	106.45	171.03	-2,662.51	1,136.82	9,792.14	-1,004.14
Total Debt/Capital (%)	28.01	19.72	14.37	16.19	22.36	19.13	22.41	36.1	48.9	51.56	63.1	103.9	91.91	98.99	111.06
Total Debt/Total Assets (%)	21.24	15.23	10.96	12.27	17.85	15.05	18.02	29.4	40.85	42.92	54.68	44.42	50.65	54.66	61.42
Net Debt to Equity	24.29	16.95	9.83	12.9	22.35	19.39	26.29	54.75	82.22	95.05	267.32	-1,951.63	1,027.01	9,144.54	-837.15
Net Debt/Capital (%)	19.54	14.5	8.95	11.43	18	16.02	20.58	35.08	42.04	46.17	99.04	92.44	88.38	98.61	107.17
EBITDA	20	32	27	26	23	28	26	23	10	24	15	-7	1	-4	- -
EBITDA-CapEx	15	23	12	8	-17	5	-8	-22	-17	-1	-15	-28	-18	-17	- -
Operating Income (Loss)	15	25	20	18	13	17	14	7	-9	5	-3	-20	-7	-12	- -

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2025 Y
As of date	05/31/2012	05/31/2013	05/31/2014	05/31/2015	05/31/2016	05/31/2017	05/31/2018	05/31/2019	05/31/2020	05/31/2021	05/31/2022	05/31/2023	05/31/2024	05/31/2025	12/31/2025

Cash Ratio	0.33	0.3	0.29	0.25	0.18	0.12	0.03	0.01	- -	0.01	0.01	0.49	0.22	0.27	0.74
Current Ratio	1.22	1.69	1.88	1.66	1.53	1.58	1.1	0.97	0.96	1.46	0.66	2.39	2.08	2.84	3.49
Quick Ratio	0.82	1.13	1.26	1.08	1	1.01	0.64	0.52	0.47	0.42	0.22	1.22	1.02	1.72	2.18
CFO/Avg Current Liab	0.46	0.36	0.42	0.51	0.37	0.55	0.28	0.14	-0.11	0.12	-0.16	-0.16	0.01	-0.01	- -
Common Equity/Total Assets	53.92	61.42	64.75	63.05	61.5	63.19	62.41	52.04	42.68	40.32	31.97	-1.67	4.46	0.56	-6.12
Long-Term Debt/Equity (%)	26.59	19.05	13.83	15.52	23.44	20.18	16.23	33.58	55.29	91.36	8.72	- -	1,093.46	9,505.91	- -
Long-Term Debt/Capital (%)	19.14	15.3	11.84	13.01	18.2	16.32	12.6	21.46	28.25	44.25	3.22	102.2	88.41	96.1	110.03
Long-Term Debt/Total Assets (%)	14.51	11.81	9.03	9.86	14.53	12.84	10.13	17.48	23.6	36.84	2.79	43.69	48.72	53.06	60.85
Total Debt/Equity (%)	38.92	24.56	16.79	19.32	28.8	23.66	28.88	56.49	95.7	106.45	171.03	-2,662.51	1,136.82	9,792.14	-1,004.14
Total Debt/Capital (%)	28.01	19.72	14.37	16.19	22.36	19.13	22.41	36.1	48.9	51.56	63.1	103.9	91.91	98.99	111.06
Total Debt/Total Assets (%)	21.24	15.23	10.96	12.27	17.85	15.05	18.02	29.4	40.85	42.92	54.68	44.42	50.65	54.66	61.42
CFO/Total Liabilities	17.59	19.21	19.33	21.07	15.93	22.87	13	6.44	-5.49	5.49	-12.09	-6.77	0.11	-0.09	- -
CFO/CapEx	4.13	2.39	1.41	1.52	0.52	1.3	0.59	0.36	-0.64	0.65	-0.75	-0.81	0.01	-0.02	- -
Altman's Z-Score	3.4	5.5	5.13	5.01	3.88	4.19	3.77	2.54	1.11	1.21	0.58	-0.06	0.12	0.05	-0.36

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2025 Y
As of date	05/31/2012	05/31/2013	05/31/2014	05/31/2015	05/31/2016	05/31/2017	05/31/2018	05/31/2019	05/31/2020	05/31/2021	05/31/2022	05/31/2023	05/31/2024	05/31/2025	12/31/2025

Accounts Receivable Turnover	11.68	12.8	11.71	11.83	10.27	10.18	10.51	9.03	2.2	1.72	2.79	3.07	4.57	4.62	- -
Days Sales Outstanding	31.25	28.52	31.18	30.87	35.54	35.86	34.74	40.4	166.2	212.83	130.79	119	79.83	78.98	- -
Inventory Turnover	12.59	16.43	16.96	19.04	16.22	15.89	16.09	11.09	2	0.96	1.46	1.96	2.14	2.45	- -
Days Inventory Outstanding	29	22.21	21.52	19.17	22.5	22.97	22.69	32.92	182.14	381.24	250.42	186.27	170.69	148.92	- -
Accounts Payable Turnover	13.21	13.69	12.89	14.13	12.46	14.02	15.34	11.26	2.52	1.73	3.09	4.57	4.45	6.59	-0.46
Accounts Payable Turnover Days	27.63	26.67	28.32	25.84	29.29	26.03	23.79	32.43	145.08	211.24	118.29	79.83	81.98	55.4	-800.3
Cash Conversion Cycle	32.62	24.06	24.39	24.2	28.75	32.8	33.64	40.89	203.26	382.83	262.92	225.45	168.54	172.5	- -
Inventory to Cash Days	2.25	6.3	9.66	11.7	13.05	12.89	12.04	7.49	-15.94	-168.42	-119.63	-67.27	-90.86	-69.93	- -
Inventories	22	24	25	25	26	24	32	54	66	63	36	41	40	32	29
Raw Materials	10	9	10	10	10	10	15	23	26	17	15	18	13	10	10
Work In Process	3	4	3	2	4	3	4	4	5	6	7	10	12	9	7
Finished Goods	9	11	11	13	12	10	13	27	35	40	13	13	15	13	12
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2025 Y
As of date	05/31/2012	05/31/2013	05/31/2014	05/31/2015	05/31/2016	05/31/2017	05/31/2018	05/31/2019	05/31/2020	05/31/2021	05/31/2022	05/31/2023	05/31/2024	05/31/2025	12/31/2025

Market Capitalization	187	371	322	386	314	385	391	289	312	351	280	242	178	251	307
- Cash & Cash Equivalents	22	14	14	14	10	6	3	1	- -	1	1	19	8	8	17
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	2	2	2	2	2	2	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	59	44	34	43	61	54	73	153	221	216	150	113	129	131	143
Enterprise Value	226	401	344	416	367	435	461	440	533	566	430	335	299	373	432
Total Capital	211	225	239	263	273	282	326	423	452	419	238	108	140	132	128
Total Debt/Capital (%)	28.01	19.72	14.37	16.19	22.36	19.13	22.41	36.1	48.9	51.56	63.1	103.9	91.91	98.99	111.06
Total Debt / EV	0.26	0.11	0.1	0.1	0.17	0.12	0.16	0.35	0.42	0.38	0.35	0.34	0.43	0.35	0.33
EV/Sales	0.71	0.91	0.72	0.77	0.77	0.92	0.88	0.79	3.33	5.61	3.86	3.25	2.33	2.9	- -
EV/EBITDA	11.19	12.48	12.59	16.27	16.13	15.56	17.72	19.39	53.42	23.19	29.37	- -	389.89	- -	- -
EV/EBIT	15.51	16.14	17.03	22.52	27.46	25.19	33.9	58.89	- -	124.85	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	9.92	17.72	15.55	14.96	16.71	13.95	20.17	23.09	- -	24.08	- -	1,491.94	16.54	16.98	- -
EV/Free Cash Flow to Firm	8.03	12.73	9.29	9.18	5.96	8.02	8.16	6.9	41.09	11.61	22.71	15.44	8.19	10.54	- -
Diluted Market Cap	191	374	326	391	314	387	394	289	312	351	280	245	214	236	- -
Diluted Enterprise Value	230	406	348	421	367	437	464	440	533	566	430	339	334	358	125
EV per Share	8.82	15.21	12.82	15.4	13.53	15.8	16.63	15.13	18.22	19.29	14.56	11.36	9.77	10.08	11.52
TTM Sales	318	442	477	539	477	470	524	558	160	101	111	103	128	129	- -
TTM EBITDA	20	32	27	26	23	28	26	23	10	24	15	-7	1	-4	- -
TTM Operating Income	15	25	20	18	13	17	14	7	-9	5	-3	-20	-7	-12	- -
TTM Cash Flow to Firm	23	23	22	28	22	31	23	19	-14	23	-11	- -	18	22	- -
TTM Free Cash Flow to Firm	28	32	37	45	62	54	56	64	13	49	19	22	36	35	- -

Multiples (USD)

Valuation Multiples API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2025 Y
As of date	05/31/2012	05/31/2013	05/31/2014	05/31/2015	05/31/2016	05/31/2017	05/31/2018	05/31/2019	05/31/2020	05/31/2021	05/31/2022	05/31/2023	05/31/2024	05/31/2025	12/31/2025

Price/Free Cash Flow	6.93	12.42	9.06	8.85	5.2	7.33	7.38	4.75	32.33	8.42	38.16	60.74	11.48	17.85	- -
EV/EBIT	15.51	16.14	17.03	22.52	27.46	25.19	33.9	58.89	- -	124.85	- -	- -	- -	- -	- -
Enterprise Value	226	401	344	416	367	435	461	440	533	566	430	335	299	373	432
Low Price	4.85	6.72	9.84	10.75	9.48	9.85	11.42	9.02	7.53	7.48	7.65	1.52	4.5	3.68	4.76
EV/Sales	0.71	0.91	0.72	0.77	0.77	0.92	0.88	0.79	3.33	5.61	3.86	3.25	2.33	2.9	- -
EV/EBITDA	11.19	12.48	12.59	16.27	16.13	15.56	17.72	19.39	53.42	23.19	29.37	- -	389.89	- -	- -
Price/Earnings	14.77	16.41	16.82	28.48	- -	36.35	15.73	702.44	- -	- -	- -	- -	14.81	- -	- -
Price/Earnings Average	12.34	12.54	17.32	26.25	-28.45	33.36	14.74	911.11	-8.04	-9.56	-2.67	-2.31	19.14	-4.96	- -
Price/Earnings High	15.03	17.14	22.35	30.21	-34.94	40.25	16.68	1,104.64	-9.53	-11.41	-3.26	-3.6	29.06	-6.62	- -
Price/Earnings Low	9.8	7.86	13.78	21.42	-22.11	25.58	12.74	638.71	-5.76	-6.79	-1.93	-0.46	11.42	-3.05	- -
Price/Book Value	1.25	2.07	1.59	1.77	1.49	1.7	1.55	1.07	1.35	1.73	3.19	-57.14	15.77	187.63	-21.59
Price/Book Value Average	1.05	1.58	1.63	1.63	1.57	1.56	1.45	1.39	1.33	1.52	3.55	-53.43	20.38	166.04	-18.46
Price/Book Value High	1.27	2.17	2.11	1.87	1.93	1.88	1.64	1.68	1.58	1.82	4.33	-83.45	30.94	221.44	-23.35
Price/Book Value Low	0.83	0.99	1.3	1.33	1.22	1.2	1.25	0.97	0.95	1.08	2.57	-10.61	12.15	101.99	-12.56
Price/Tangible Book Value	4.56	5.22	3.34	3.43	2.25	2.58	2.22	1.95	2.52	2.45	4.02	-10.83	-69.56	-19.98	-10.92
Price/Tangible Book Value Average	3.81	3.99	3.44	3.16	2.37	2.37	2.08	2.53	2.49	2.15	4.47	-10.13	-89.88	-17.68	-9.33
Price/Tangible Book Value High	4.64	5.45	4.44	3.64	2.91	2.86	2.35	3.06	2.95	2.57	5.45	-15.82	-136.44	-23.58	-11.81
Price/Tangible Book Value Low	3.02	2.5	2.74	2.58	1.84	1.81	1.8	1.77	1.78	1.53	3.24	-2.01	-53.6	-10.86	-6.35
Price/Sales	0.59	0.84	0.68	0.72	0.66	0.82	0.75	0.52	1.95	3.48	2.52	2.38	1.39	1.83	- -
Price/Sales Average	0.49	0.64	0.7	0.66	0.69	0.75	0.7	0.67	1.92	3.06	2.8	2.22	1.79	1.62	- -
Price/Sales High	0.6	0.88	0.9	0.76	0.85	0.91	0.79	0.81	2.27	3.65	3.42	3.47	2.72	2.16	- -
Price/Sales Low	0.39	0.4	0.55	0.54	0.54	0.58	0.6	0.47	1.37	2.18	2.03	0.44	1.07	0.99	- -
Price/Cash Flow	8.45	17.46	15.3	14.49	15.14	12.9	19.75	18.02	-18.3	21.32	-12.41	-14.07	692.48	-1,144.29	- -
Price/Cash Flow Average	7.06	13.34	15.75	13.36	15.95	11.84	18.5	23.37	-18.03	18.74	-13.79	-13.16	894.79	-1,012.62	- -
Price/Cash Flow High	8.6	18.23	20.34	15.37	19.59	14.29	20.94	28.34	-21.37	22.37	-16.83	-20.55	1,358.29	-1,350.5	- -
Price/Cash Flow Low	5.61	8.36	12.54	10.9	12.4	9.08	15.99	16.39	-12.91	13.32	-9.99	-2.61	533.59	-622.01	- -
Price/Free Cash Flow Average	5.79	9.48	9.33	8.16	5.48	6.72	6.91	6.16	31.85	7.4	42.4	56.79	14.83	15.79	- -
Price/Free Cash Flow High	7.05	12.96	12.05	9.39	6.73	8.11	7.82	7.47	37.75	8.84	51.74	88.69	22.51	21.06	- -
Price/Free Cash Flow Low	4.6	5.94	7.43	6.66	4.26	5.15	5.97	4.32	22.82	5.26	30.73	11.27	8.84	9.7	- -
EV/Sales Average	0.62	0.71	0.74	0.72	0.81	0.86	0.83	0.94	3.3	5.19	4.14	3.09	2.74	2.67	- -
EV/Sales High	0.72	0.95	0.94	0.81	0.96	1.01	0.92	1.09	3.65	5.78	4.76	4.32	3.67	3.25	- -
EV/Sales Low	0.51	0.47	0.6	0.59	0.65	0.68	0.74	0.74	2.75	4.3	3.37	1.34	2.01	2.01	- -
EV/EBITDA Average	9.67	9.81	12.94	15.09	16.87	14.42	16.77	23.17	52.96	21.45	31.5	-48.84	457.96	-86.55	- -
EV/EBITDA High	11.36	13.04	16.47	17.19	20.19	17.04	18.62	26.67	58.67	23.9	36.18	-68.24	613.93	-105.15	- -
EV/EBITDA Low	8.07	6.52	10.46	12.53	13.63	11.47	14.86	18.23	44.22	17.79	25.63	-21.15	336.43	-65.05	- -
EV/EBIT Average	13.4	12.69	17.5	20.89	28.72	23.35	32.08	70.37	-59.53	115.47	-134.25	-16.2	-48.8	-28.68	- -
EV/EBIT High	15.74	16.86	22.28	23.79	34.37	27.58	35.64	81.01	-65.95	128.67	-154.24	-22.64	-65.42	-34.85	- -
EV/EBIT Low	11.18	8.43	14.15	17.35	23.2	18.58	28.44	55.39	-49.7	95.79	-109.26	-7.02	-35.85	-21.56	- -
Last Price	7.31	14.04	12.01	14.29	11.58	14	14.1	9.92	10.67	11.97	9.5	8.19	5.84	6.77	8.18
High Price	7.44	14.66	15.96	15.16	14.98	15.5	14.95	15.6	12.46	12.56	12.88	11.96	11.46	7.99	8.85
Enterprise Value Average	195	315	353	386	384	403	436	526	528	523	461	320	351	344	387
Enterprise Value High	229	419	450	439	460	476	484	606	585	583	529	447	470	418	457
Enterprise Value Low	163	210	286	320	310	320	386	414	441	434	375	138	258	259	304

Shares Outstanding	26	26	27	27	27	27	28	29	29	29	30	30	31	37	37
Diluted Weighted Avg Shares	26	27	27	27	27	28	28	29	29	29	30	30	37	35	- -
Basic Weighted Avg Shares	26	26	27	27	27	27	28	29	29	29	30	30	30	35	- -
Revenue per Share	12.38	16.73	17.78	19.98	17.57	17.08	18.92	19.16	5.48	3.44	3.77	3.45	4.21	3.7	- -
EBITDA per Share	0.79	1.22	1.02	0.95	0.84	1.02	0.94	0.78	0.34	0.83	0.5	-0.22	0.03	-0.11	- -
Operating Income per Share	0.57	0.94	0.75	0.68	0.49	0.63	0.49	0.26	-0.3	0.15	-0.12	-0.66	-0.24	-0.34	- -
Basic EPS, GAAP	0.5	0.86	0.71	0.5	-0.43	0.39	0.9	0.01	-1.31	-1.1	-3.95	-3.32	0.39	-1.21	- -
Basic EPS from Cont Ops	0.51	0.86	0.72	0.51	-0.44	0.37	0.93	0.07	-0.75	-0.8	-0.52	-2.14	0.31	-1.11	- -
Diluted EPS, GAAP	0.49	0.85	0.71	0.5	-0.43	0.38	0.89	0.01	-1.31	-1.1	-3.95	-3.32	0.33	-1.21	- -
Diluted EPS from Cont Ops	0.5	0.86	0.71	0.5	-0.44	0.37	0.92	0.07	-0.75	-0.8	-0.52	-2.14	0.25	-1.11	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	0.86	0.8	0.78	0.99	0.76	1.09	0.71	0.55	-0.58	0.56	-0.77	-0.58	0.01	-0.01	- -
Free Cash Flow per Basic Share	0.66	0.47	0.23	0.34	-0.7	0.25	-0.5	-0.99	-1.5	-0.3	-1.78	-1.3	-0.6	-0.39	- -
Cash & Equivalents per Share	0.86	0.58	0.53	0.52	0.36	0.22	0.1	0.04	0.01	0.04	0.03	0.65	0.28	0.22	0.47
Book Value per Share	5.84	6.77	7.57	8.09	7.76	8.24	9.12	9.28	7.91	6.91	2.98	-0.14	0.37	0.04	-0.38
Tangible Book Value per Share	1.6	2.69	3.59	4.17	5.15	5.43	6.36	5.09	4.23	4.88	2.36	-0.76	-0.08	-0.34	-0.75

Lifecore Biomedical, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)